Tag: #M&A

The Vietnamese pharmaceutical sector has witnessed a major ownership transition at Imexpharm Pharmaceutical JSC (HoSE: IMP). Following a successful public... Read more

Gilead Sciences has concluded its merger with Arcellx, a move designed to secure full rights to an investigational cell therapy... Read more

Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon for an enterprise valuation of $11.75 billion in... Read more

Eli Lilly has agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, featuring an upfront... Read more

Servier, a global independent pharmaceutical group, has concluded its tender offer for Day One Biopharmaceuticals, acquiring all outstanding common stock... Read more

On April 22, 2026, Amneal Pharmaceuticals announced its strategic acquisition of Kashiv BioSciences for $1.1 billion. This move positions Amneal... Read more

Eli Lilly has entered into a definitive agreement to acquire Kelonia Therapeutics for potential consideration of up to $7 billion.... Read more

Belgian pharmaceutical giant UCB announced on Friday its acquisition of Neurona Therapeutics for up to $1.2 billion. The move highlights... Read more

Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more